Filing Flows › Lucid Diagnostics (LUCD) › Q2 2026
Lucid Diagnostics (LUCD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 12, 2026
Lucid Diagnostics (LUCD) reported revenue of $1.5M for the second quarter 2026 (Q2 2026), +27% from a year earlier and +17% from the quarter before. Operating margin was -868.5%, net loss $11.7M (792.9% of revenue).
Lucid Diagnostics, Q2 2026: revenue $1.5M (+27% year over year), operating margin -868.5%, net loss $11.7M, operating cash flow −$11.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | +17% | +27% |
| Operating profit | −$12.8M | — | — |
| Net earnings | −$11.7M | — | — |
| Operating cash flow | −$11.3M | — | — |
What changed
Revenue was $1.5M in Q2 2026, up 27% year over year and up 17% from the previous quarter.
Operating costs exceeded revenue by $12.8M, an operating margin of -868.5%. Total costs grew 14% against revenue growth of 27%. The fastest-growing cost line was Sales & marketing (+44%). The quarter ended with a net loss of $11.7M, narrower than the previous quarter's $13.9M loss.
Operating cash flow was −$11.3M. Non-cash charges added back $224K of depreciation and amortization and $1.7M of share-based compensation. Working capital and other items used $1.5M. Capital expenditures of $21K exceeded it, leaving free cash flow of −$11.3M.
Questions
What was Lucid Diagnostics' revenue in the second quarter 2026?
Lucid Diagnostics (LUCD) reported revenue of $1.5M for the second quarter 2026 (Q2 2026), +27% from a year earlier and +17% from the quarter before.
Was Lucid Diagnostics profitable in the second quarter 2026?
Operating loss was $12.8M (-868.5% of revenue) and net loss $11.7M.
Source: Lucid Diagnostics 10-Q on SEC EDGAR.